Salarinejad S - Search Results

1

6-Cinnamoyl-4-arylaminothienopyrimidines as highly potent cytotoxic agents: Design, synthesis and structure-activity relationship studies.

Toolabi M, Moghimi S, Bakhshaiesh TO, Salarinejad S, Aghcheli A, Hasanvand Z, Nazeri E, Khalaj A, Esmaeili R, Foroumadi A. Toolabi M, et al. Among authors: salarinejad s. Eur J Med Chem. 2020 Jan 1;185:111786. doi: 10.1016/j.ejmech.2019.111786. Epub 2019 Oct 18. Eur J Med Chem. 2020. PMID: 31671308

2

A review on progression of epidermal growth factor receptor (EGFR) inhibitors as an efficient approach in cancer targeted therapy.

Ayati A, Moghimi S, Salarinejad S, Safavi M, Pouramiri B, Foroumadi A. Ayati A, et al. Among authors: salarinejad s. Bioorg Chem. 2020 Jun;99:103811. doi: 10.1016/j.bioorg.2020.103811. Epub 2020 Apr 2. Bioorg Chem. 2020. PMID: 32278207 Review.

3

Design and synthesis of novel pyridazine N-aryl acetamides: In-vitro evaluation of α-glucosidase inhibition, docking, and kinetic studies.

Moghimi S, Toolabi M, Salarinejad S, Firoozpour L, Sadat Ebrahimi SE, Safari F, Mojtabavi S, Faramarzi MA, Foroumadi A. Moghimi S, et al. Among authors: salarinejad s. Bioorg Chem. 2020 Sep;102:104071. doi: 10.1016/j.bioorg.2020.104071. Epub 2020 Jul 6. Bioorg Chem. 2020. PMID: 32688112

4

Design, synthesis, molecular docking study, and antibacterial evaluation of some new fluoroquinolone analogues bearing a quinazolinone moiety.

Norouzbahari M, Salarinejad S, Güran M, Şanlıtürk G, Emamgholipour Z, Bijanzadeh HR, Toolabi M, Foroumadi A. Norouzbahari M, et al. Among authors: salarinejad s. Daru. 2020 Dec;28(2):661-672. doi: 10.1007/s40199-020-00373-6. Epub 2020 Oct 8. Daru. 2020. PMID: 33030668 Free PMC article.

5

Synthesis, in-vitro evaluation, molecular docking, and kinetic studies of pyridazine-triazole hybrid system as novel α-glucosidase inhibitors.

Moghimi S, Salarinejad S, Toolabi M, Firoozpour L, Esmaeil Sadat Ebrahimi S, Safari F, Madani-Qamsari F, Mojtabavi S, Faramarzi MA, Karima S, Pakrad R, Foroumadi A. Moghimi S, et al. Among authors: salarinejad s. Bioorg Chem. 2021 Apr;109:104670. doi: 10.1016/j.bioorg.2021.104670. Epub 2021 Feb 1. Bioorg Chem. 2021. PMID: 33588241

6

Synthesis of novel 2-acetamide-5-phenylthio-1,3,4-thiadiazole-containing phenyl urea derivatives as potential VEGFR-2 inhibitors.

Toolabi M, Safari F, Ayati A, Fathi P, Moghimi S, Salarinejad S, Foroumadi R, Ketabforoosh SHME, Foroumadi A. Toolabi M, et al. Among authors: salarinejad s. Arch Pharm (Weinheim). 2022 Mar;355(3):e2100397. doi: 10.1002/ardp.202100397. Epub 2022 Jan 10. Arch Pharm (Weinheim). 2022. PMID: 35014090

7

Synthesis, α-Glucosidase inhibitory activity and docking studies of Novel Ethyl 1,2,3-triazol-4-ylmethylthio-5,6-diphenylpyridazine-4-carboxylate derivatives.

Firoozpour L, Moghimi S, Salarinejad S, Toolabi M, Rafsanjani M, Pakrad R, Salmani F, Shokrolahi SM, Sadat Ebrahimi SE, Karima S, Foroumadi A. Firoozpour L, et al. Among authors: salarinejad s. BMC Chem. 2023 Jun 26;17(1):66. doi: 10.1186/s13065-023-00973-8. BMC Chem. 2023. PMID: 37365646 Free PMC article.

8

Synthesis, biological activities, and molecular docking studies of triazolo[4,3-b]triazine derivatives as a novel class of α-glucosidase and α-amylase inhibitors.

Seyfi S, Salarinejad S, Moghimi S, Toolabi M, Sadeghian N, Tüzün B, Firoozpour L, Ketabforoosh SHME, Taslimi P, Foroumadi A. Seyfi S, et al. Among authors: salarinejad s. Arch Pharm (Weinheim). 2024 Mar 19:e2300628. doi: 10.1002/ardp.202300628. Online ahead of print. Arch Pharm (Weinheim). 2024. PMID: 38501879

9

Design, synthesis, and biological evaluation of new biaryl derivatives of cycloalkyl diacetamide bearing chalcone moiety as type II c-MET kinase inhibitors.

Salarinejad S, Seyfi S, Hayashi S, Moghimi S, Toolabi M, Taslimi P, Firoozpour L, Usui T, Foroumadi A. Salarinejad S, et al. Mol Divers. 2024 Mar 11. doi: 10.1007/s11030-024-10807-x. Online ahead of print. Mol Divers. 2024. PMID: 38466553

10

A case report of aggressive mixed epithelial and stromal tumor of the kidney with malignant transformation.

Ansari Djafari A, Rahnama H, Javanmard B, Hojjati SA, Salarinejad S. Ansari Djafari A, et al. Among authors: salarinejad s. Urol Case Rep. 2024 Feb 22;53:102689. doi: 10.1016/j.eucr.2024.102689. eCollection 2024 Mar. Urol Case Rep. 2024. PMID: 38440418 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

20 results

Search Page